Isabel Recio

Hospital De Gran Canaria Dr. Negrin
Las Palmas De Gran Canaria, CN 35010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.

Journal: Cancers

Published: April 09, 2022

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience.

Journal: Cancers

Published: February 22, 2022

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.

Journal: Scientific reports

Published: June 07, 2021

Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.

Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: October 02, 2017

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.

Journal: PloS one

Published: October 12, 2015

A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.

A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.

Journal: Hematological oncology

Published: November 23, 2014

Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.

Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.

Journal: Annals of hematology

Published: March 05, 2013

Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.

Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.

Journal: PloS one

Published: July 11, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026